2022 | Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib | Perl, Alexander E; Hosono, Naoko; Montesinos, Pau; Podoltsev, Nikolai; Martinelli, Giovanni; Panoskaltsis, Nicki; Recher, Christian; Smith, Catherine C; Levis, Mark J; Strickland, Stephen; Röllig, Christoph; Groß-Langenhoff, Marco; WEN-CHIEN CHOU ; Lee, Je-Hwan; Yokoyama, Hisayuki; Hasabou, Nahla; Lu, Qiaoyang; Tiu, Ramon V; Altman, Jessica K | Blood cancer journal | 20 | 17 | |